Bioresonance therapy in the rehabilitation of post−traumatic syndromes using the multiphysics device Muflon−X

Background: This study evaluates the clinical efficacy of bioresonance therapy (BRT) in the rehabilitation of patients with post−traumatic syndrome (PTS). Objective: To assess the impact of BRT using the MUFLON−X device on clinical, immunological, metabolic, and psycho−emotional parameters. Methods: A prospective randomized clinical trial was conducted involving patients. This study presents the results of a prospective randomized clinical trial evaluating the efficacy of bioresonance therapy (BRT) in the rehabilitation of 135 patients with post−traumatic syndrome (PTS). Conducted using the multiphysical device “Muflon−X,” developed at the National Technical University “Kharkiv Polytechnic Institute,” the trial compared three groups: standard treatment, BRT alone, and combined therapy. Clinical, immunological, metabolic, and psycho−emotional parameters were assessed. Results:. The combined therapy group demonstrated the most significant improvements, including reduced pain (VAS −5.6), improved sleep (PSQI +4.8), decreased inflammation (CRP −9.7 mg/L), and enhanced immune response (IgG +2.6 g/L, CD3+ +13.4%). Rehabilitation time was reduced by 49%, and medication costs decreased by up to 31%. Conclusions. The study highlights the potential of BRT as a non−invasive, adjunctive modality in PTS management, particularly in military and post−conflict settings. The combined therapy group showed the most significant improvements in pain reduction, sleep quality, inflammation markers, and immune response The findings support further investigation into long−term outcomes, neuroplasticity, and integration of BRT into clinical protocols. This research provides a methodological foundation for expanding the use of BRT in evidence−based rehabilitation medicine.